Dr Patricia Ares-Romero and Dr Martin Rosenzweig discuss treatment strategies for TRD, including alternative therapies and explain current barriers within the healthcare system that inhibit access.

In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...

Carrie Jardine leads a discussion on varying prior authorization policies for alternative therapies for TRD along with implications to patients.

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

Imitation Ozempic products pose serious health risks to consumers Brand-name Ozempic costs $800-$1,000 per month, limiting ...